Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.
about
Clinical application of a 3D ultrasound-guided prostate biopsy systemESUR prostate MR guidelines 2012Role of multiparametric magnetic resonance imaging in early detection of prostate cancerClinical applications for diffusion magnetic resonance imaging in radiotherapyMultiparametric-MRI in diagnosis of prostate cancerAcoustic radiation force impulse imaging of human prostates: initial in vivo demonstration.Microvascularity in transition zone prostate tumors resembles normal prostatic tissue.The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis ChallengeQuantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging.Zinc-sensitive MRI contrast agent detects differential release of Zn(II) ions from the healthy vs. malignant mouse prostateReview of Prostate Imaging Reporting and Data System version 2.Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation.Cell membrane water exchange effects in prostate DCE-MRI.Diffusion-weighted MRI and its role in prostate cancer.High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressivenessEvaluation of the normal-to-diseased apparent diffusion coefficient ratio as an indicator of prostate cancer aggressiveness.Interactive Feature Space Explorer© for multi-modal magnetic resonance imaging.Automated prostate cancer detection via comprehensive multi-parametric magnetic resonance imaging texture feature models.Defining the radiobiology of prostate cancer progression: An important question in translational prostate cancer research.Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications.False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillancePredicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker.Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery.Magnetic Resonance Imaging of the Prostate, Including Pre- and Postinterventions.Nonvisible tumors on multiparametric magnetic resonance imaging does not predict low-risk prostate cancer.Computer-extracted Features Can Distinguish Noncancerous Confounding Disease from Prostatic Adenocarcinoma at Multiparametric MR Imaging.Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate CancerImaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical OverviewMagnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancerIn vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.Integrating multiparametric prostate MRI into clinical practice.The emerging role of diffusion-weighted MRI in prostate cancer management.Oncologic applications of diffusion-weighted MRI in the body.Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.Functional and molecular imaging of localized and recurrent prostate cancer.Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.MRI-based prostate volume-adjusted prostate-specific antigen in the diagnosis of prostate cancer.Addressing the need for repeat prostate biopsy: new technology and approaches.Pitfalls in Interpreting mp-MRI of the Prostate: A Pictorial Review with Pathologic Correlation.Score 3 prostate lesions: a gray zone for PI-RADS v2.
P2860
Q24608010-85B54980-19E3-44CD-A4E9-948700790241Q24620926-F85D3F5D-1F5D-4A10-A008-C2F049847DB8Q26768765-483D0704-EA1A-48A4-BBDB-9AA130EA77B9Q27005757-81577FF3-618D-4E17-8B6E-FCCA4701E02BQ28081873-A6229FF3-EB09-4E36-9052-41C18C8A051CQ30459679-95DE32E1-2271-4B2B-9E66-9439BE4233F3Q31097312-F1CC2ACD-6092-43AA-ABF4-E089179AE8C9Q31097630-B37EE266-3C4D-49F8-8D7A-049B74E8616EQ31123327-5ACBBE80-F1B3-41F0-AFA5-E65C44AA5883Q31123635-1B708FF6-5396-42C7-A29E-41D31CA03664Q31131775-1F18C27A-2618-4593-9DDC-D1E00593399BQ33870183-3843B699-CECA-4378-BFF2-1451E1615EC1Q34266549-3340EFF0-2C8C-45EC-B1F2-4E5FE6BCCACFQ34742733-24E6104E-9D0F-4F28-B185-793C40978EAAQ35164071-26539113-F084-4CAE-8D05-DC2195D8B9FDQ35178690-21388766-3415-4FF0-81F7-0C874857D389Q35690565-33137FAB-DB0F-4AE9-B0DF-61452CCA86E2Q35737796-BA41AF80-FB24-4075-8FDA-596422E7FF22Q35772886-3C549933-0945-49D7-AC62-3C42FDDD3ABCQ35773547-DF6EDEFF-3CA4-4FF4-9FA5-225E01532965Q35902253-01E90DE9-CACC-4FD5-B291-192B689ECBD8Q35952787-4B0A2906-6330-4BAB-8461-29809702A0ADQ36004153-F6530E8A-C5AA-4EBF-825F-30FA4113CB04Q36119374-4696CBC9-A3FA-42C3-8CED-F03DF0066474Q36387925-A4E61906-99ED-4EA8-A379-8794D623040EQ36425353-E96BCED9-A312-4205-B46D-87DF4C1711E3Q36727030-DF896FF1-E4DF-40B6-8463-79F1F1ACE6ECQ36979944-B3364FCF-396D-45C6-8711-D3FACADAE7FAQ37018444-C4F18B43-01F6-4C09-8BF2-1834C11DC9E7Q37685320-9EFB29D1-272B-449B-8D43-6AE944CB20ACQ37970305-DBADDB1E-D725-4524-A5DC-54507B6D8751Q37976257-7E3836C8-F2D5-4E40-B66D-A5FE50245517Q37978220-13ED6859-52A7-4328-9BDC-BF33DBE4F6C1Q38100740-47DF8D5D-6417-4831-B853-A62C0D867B80Q38104639-E0A814C1-CD10-43EA-9A44-550A57059E40Q38385402-B9B67511-423C-43F8-9943-F1CCE2825B22Q38462421-0E2576C1-816A-4FE9-964B-2CF333051134Q38546671-DF87D532-6BB8-436E-80A1-F7451C09A823Q38589371-3DE604E1-D1CC-4FF4-A2CE-480A4236E6F5Q38598713-70D2FAC8-F209-41D8-9E71-ECED3B2A7E17
P2860
Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prostate cancer: differentiati ...... contrast-enhanced MR imaging.
@en
Prostate cancer: differentiati ...... contrast-enhanced MR imaging.
@nl
type
label
Prostate cancer: differentiati ...... contrast-enhanced MR imaging.
@en
Prostate cancer: differentiati ...... contrast-enhanced MR imaging.
@nl
prefLabel
Prostate cancer: differentiati ...... contrast-enhanced MR imaging.
@en
Prostate cancer: differentiati ...... contrast-enhanced MR imaging.
@nl
P2093
P356
P1433
P1476
Prostate cancer: differentiati ...... c contrast-enhanced MR imaging
@en
P2093
Arda Kayhan
Arieh L Shalhav
Aytekin Oto
Cheng Yang
Farid Dahi
Gregory Karczmar
Maria Tretiakova
Tatjana Antic
Walter M Stadler
Yulei Jiang
P304
P356
10.1148/RADIOL.10100021
P407
P577
2010-09-15T00:00:00Z